Literature DB >> 304741

F20C, a new fluorescent membrane probe, moves more slowly in malignant and mitogen-transformed cell membranes than in normal cell membranes.

N S Kosower, E M Kosower, S Lustig, D H Pluznik.   

Abstract

New fluorescent probes of membrane mobility can be introduced into cell membranes at single points with particles of a membrane mobility agent, A2C. The initial entry of fluorescence from the particle into the cell membrane and the subsequent lateral spread of fluorescence have been observed for cells in suspension. A dramatic difference between the behavior of normal lymphocytes and that of mitogen-transformed and mastocytoma cells is found. Both the initial entry and the spreading of fluorescence are much slower in the transformed and tumor cells than in the normal cells at 18 degrees C. Entry and spread of fluorescence in normal cells become slow enough to be observed only at 12 degrees C or below.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 304741     DOI: 10.1016/0005-2736(78)90380-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Bimane fluorescent labels: labeling of normal human red cells under physiological conditions.

Authors:  N S Kosower; E M Kosower; G L Newton; H M Ranney
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

2.  Membrane-mobility agent-promoted fusion of erythrocytes: fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins.

Authors:  N S Kosower; T Glaser; E M Kosower
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

3.  Effects of irradiation on the interaction of fluorescent probes with lymphocytes.

Authors:  J C Standefer; R E Anderson; M Wilder; J Martin
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

Review 4.  Fluorescent probes to detect lymphocyte activation.

Authors:  R C Nairn; J M Rolland
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.